Skip to content

Author

Yu-Mei Hao

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Trehalose-modulated poloxamer 407 thermosensitive hydrogel: sol-gel transition regulation and sustained low-dose pilocarpine nitrate delivery.

Traditional ophthalmic solutions and viscous gels are limited by insufficient precorneal residence time, inaccurate dosing administration, and inconvenient sterile filtration. Pilocarpine, originally a classic muscarinic acetylcholine receptor agonist for glaucoma management, has been recently repurposed for presbyopia...

Hui-Hui Shao, He-Ying Jin, Yu-Mei Hao et al. · 0 citations
Aug 2026

Albumin-Coated Mesoporous Polydopamine Nanoparticles for Renal Delivery of Epigallocatechin Gallate against Cisplatin-Induced Acute Kidney Injury.

In a murine cisplatin-induced AKI model, EGCG-MPDA@BSA exhibited significantly enhanced therapeutic efficacy compared to uncoated nanoparticles and free EGCG, thereby alleviating oxidative stress, inflammation, and tubular damage.

Yi-Ge Yang, Peng Lei, Kai-Chao Song et al. · 0 citations
Open access Sep 2026

Thymine-functionalized bPEI nanocomplexes for synergistic STING activation and PD-L1 silencing to potentiate cancer immunotherapy.

In vivo studies of both anti-PD-L1-responsive and resistant tumor models demonstrated that intratumoral delivery of bPEI-Thy/siPD-L1 NCs substantially reduced tumor growth and metastatic spread, induced apoptosis, alleviated immunosuppression, and extended survival.

Li-Qing Chen, Mong-Hsiu Song, Ming-Ji Jin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.